2006
DOI: 10.1016/j.pbb.2006.04.018
|View full text |Cite
|
Sign up to set email alerts
|

In vitro and antinociceptive profile of HON0001, an orally active NMDA receptor NR2B subunit antagonist

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
20
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(22 citation statements)
references
References 17 publications
2
20
0
Order By: Relevance
“…In our study, the highest doses of MK-801 (0.03 mg/kg, s.c.) or MS (15 mg/kg, s.c.) did not cause motor impairment, which was verified by means of the rotarod test. This is supported by previous findings that low doses of MS and MK-801 do not induce adverse effect in rats (Boyce et al, 1999;Begon et al, 2000;Suetake-Koga et al, 2006;Yonehara et al, 2002). These data suggest that the analgesic effects may be obtained with MS or MK-801 without exceeding safe doses.…”
Section: Discussionsupporting
confidence: 88%
See 1 more Smart Citation
“…In our study, the highest doses of MK-801 (0.03 mg/kg, s.c.) or MS (15 mg/kg, s.c.) did not cause motor impairment, which was verified by means of the rotarod test. This is supported by previous findings that low doses of MS and MK-801 do not induce adverse effect in rats (Boyce et al, 1999;Begon et al, 2000;Suetake-Koga et al, 2006;Yonehara et al, 2002). These data suggest that the analgesic effects may be obtained with MS or MK-801 without exceeding safe doses.…”
Section: Discussionsupporting
confidence: 88%
“…In the rotarod test, the cut-off time used was 120 s (Suetake- Koga et al, 2006). The time at which the rats fell off the rotating cylinder was recorded.…”
Section: Rotarod Testmentioning
confidence: 99%
“…Preclinical pharmacological (Taniguchi et al, 1997;Boyce et al, 1999;Suetake-Koga et al, 2006) and genetic (Wei et al, 2001;Tan et al, 2005) studies indicate that GluN2B subunit-containing NMDA receptors may be specifically targeted to treat neuropathic pain (Chizh et al, 2001;Wu and Zhuo, 2009). Prompted by these data, the analgesic efficacy of a single dose of CP-101,606 was tested in a small number of patients suffering from pain due to spinal cord injury and monoradiculopathy, and a clinically meaningful reduction in reported pain was observed (Sang et al, 2003).…”
Section: N-methyl-d-aspartate Antagonistsmentioning
confidence: 99%
“…A number of studies demonstrated that ganglion cells are extremely vulnerable to exogenously applied NMDA, which inducesganglion cell degeneration.It has been also shown that NMDA receptor antagonists are neuroprotective in experimental glaucoma models [110][111][112][113][114][115][116][117]. NMDA receptors permit the influx of sodium ions (Na Although all NMDA receptors express the NR1 subunit [122,123,124], NR2 subunits are major determinants of the functional properties of NMDA receptor [125]. Recently, [126] reported the roles of the four different NR2 subtypes (NR2a, NR2b, NR2c, NR2d) in NMDA-induced retinal cell death using mice lacking specific NR2 subunits.…”
Section: A Nmda Receptorsmentioning
confidence: 99%
“…It has been reported that memantine prevents the loss of retinal ganglion cells in GLAST knockout mice, a model of normal tension glaucoma (NTG), suggesting that NR2d-containing receptors may be involved in ganglion cell loss in glaucoma [125,126]. It was also demonstrated that Mg 2+ regulates the sensitivity of NMDA receptors to memantine [133].…”
Section: B Neuroprotection By Nmda Receptor Antagonistsmentioning
confidence: 99%